129 related articles for article (PubMed ID: 16546304)
1. [Early myocardial infarction associated with chemotherapy for testicular cancer].
Bernard P; Cellarier G; Crémades S; Gisserot O; De Jauréguiberry JP
Rev Med Interne; 2006 Jun; 27(6):497-8. PubMed ID: 16546304
[TBL] [Abstract][Full Text] [Related]
2. Acute myocardial infarction in a young man receiving chemotherapy for testicular cancer: case report.
Mermershtain W; Dudnik J; Gusakova I; Ariad S
J Chemother; 2001 Dec; 13(6):658-60. PubMed ID: 11806629
[TBL] [Abstract][Full Text] [Related]
3. Acute anterior myocardial infarction after chemotherapy for testicular seminoma in a young patient.
Ozben B; Kurt R; Oflaz H; Sezer M; Basaran M; Goren T; Umman S
Clin Appl Thromb Hemost; 2007 Oct; 13(4):439-42. PubMed ID: 17911198
[TBL] [Abstract][Full Text] [Related]
4. Early myocardial infarction during chemotherapy for testicular cancer.
Bachmeyer C; Joly H; Jorest R
Tumori; 2000; 86(5):428-30. PubMed ID: 11130576
[TBL] [Abstract][Full Text] [Related]
5. Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer.
Shoji S; Miyakita H; Shima M; Usui Y; Nagata Y; Uchida T; Terachi T
Hinyokika Kiyo; 2006 Sep; 52(9):723-6. PubMed ID: 17040060
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
7. [A case of pneumomediastinum during BEP (bleomycin, etoposide, cisplatin) chemotherapy for testicular cancer].
Noguchi G; Ota J; Ishigaki H; Onuki T; Kato Y; Moriyama M
Hinyokika Kiyo; 2013 Aug; 59(8):545-9. PubMed ID: 23995535
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral infarction and myocardial infarction due to cisplatin-containing chemotherapy].
Brouha ME; Bloemendal HJ; Kappelle LJ; Winter JB
Ned Tijdschr Geneeskd; 2003 Mar; 147(10):457-60. PubMed ID: 12666519
[TBL] [Abstract][Full Text] [Related]
9. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
10. Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy.
Schwarzer S; Eber B; Greinix H; Lind P
Eur Heart J; 1991 Jun; 12(6):748-50. PubMed ID: 1713559
[TBL] [Abstract][Full Text] [Related]
11. [Randomized phase III study on nonseminomatous testicular tumor].
Rexer H
Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
[No Abstract] [Full Text] [Related]
12. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
[TBL] [Abstract][Full Text] [Related]
13. [Acute myocardial infarct following chemotherapy for testicular carcinoma: on the coronary toxicity of cytostatic agents].
Borek G; Gebel F; Jenzer HR
Schweiz Med Wochenschr; 1991 Mar; 121(11):385-9. PubMed ID: 1851325
[TBL] [Abstract][Full Text] [Related]
14. Thymic rebound in an adult following chemotherapy for testicular cancer.
Tait DM; Goldstraw P; Husband JE
Eur J Surg Oncol; 1986 Dec; 12(4):385-7. PubMed ID: 2430837
[TBL] [Abstract][Full Text] [Related]
15. Testicular cancer and platinum: a double-edged sword.
O'Reilly A; MacEneaney P; Mayer N; O'Reilly SP; Power DG
J Clin Oncol; 2014 Apr; 32(12):e46-8. PubMed ID: 24449237
[No Abstract] [Full Text] [Related]
16. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
17. [Bleomycin-induced pneumonia].
Berger K; Göpfert A; Berkel H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
[TBL] [Abstract][Full Text] [Related]
18. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
20. Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy.
Lubberts S; Boer H; Altena R; Meijer C; van Roon AM; Zwart N; Oosting SF; Kamphuisen PW; Nuver J; Smit AJ; Mulder AB; Lefrandt JD; Gietema JA
Eur J Cancer; 2016 Aug; 63():180-8. PubMed ID: 27322917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
